Rally Kid Ailani Fighting ALL Blood Cancer
H.R. 10370
Ailani Myers AIM to Cure Kids with Cancer Act
Requires connecting what we know and putting it into action faster.
The Ailani Myers AIM (Accelerating Innovation in Medicine) to Cure Kids With Cancer Act closely mirrors Executive Order 14355, Unlocking Cures for Pediatric Cancer with Artificial Intelligence (September 2025), turning it into law. The bill gives childhood cancer a permanent seat at the table across the federal government, authorizes the Childhood Cancer Data Initiative (CCDI), and harnesses AI to speed up research, diagnostics and treatment breakthroughs for kids.
The bill is named for Ailani Myers, a 10-year-old eight-time cancer fighter.
What the Bill Does
Names a Coordinator of AI Innovation
Requires every President to designate a Coordinator of AI Innovation to align pediatric cancer activities across HHS (NIH, FDA, CMS, ARPA-H, ONC), the Department of Defense Medical Research Program, DOE, VA, NSF, NIST and the White House OSTP, with patients, survivors, families, caregivers, researchers and funders as external partners.
Giving childhood cancer a permanent seat at the table.
Authorizes the Childhood Cancer Data Initiative
CCDI is currently an administrative initiative, not an authorized program. The bill authorizes CCDI under the NCI Director at $100 million each year, FY2027–2031.
- Data requirements: Directs CCDI to collect, generate, standardize, link and share data, including molecular characterization of tumors, functional precision medicine, AI and non-invasive diagnostic tools, the CCDI Data Ecosystem, rare pediatric cancer data and the National Childhood Cancer Registry, and requires the development of data standards.
- Functional precision medicine: Section 201 names functional precision medicine as a required part of CCDI for the first time.
Harnesses AI at the National Cancer Institute
The NCI Director shall support, in coordination with the Coordinator, the development and application of artificial intelligence to accelerate progress in pediatric cancer research and care, including through the CCDI.
Protects Patient Information
All federal and state laws regarding patient information will be followed.
Sets Timelines and Accountability
Sets firm deadlines, with reports submitted to the appropriate committees of Congress.
Timelines and Accountability
30 days
President notifies Congress of the coordinator
180 days
Interim report on progress, early findings and barriers
1 year, then annually through FY2031
Activities, dollars spent and outcomes for kids
2 years
ONC finalizes AI-ready interoperability standards
What Is Functional Precision Medicine?
Doctors test drugs directly on a child’s living tumor cells to see which treatments actually work.
Many pediatric cancers have few targetable mutations, so testing what works on the actual tumor can open treatment options that genetic sequencing alone would miss. It is one of the top three priorities of the NCI Director, and Section 201 of this bill names it as a required part of the CCDI for the first time.
Watch the AIM Act Webinar
A walk through the bill with Rally Foundation and Congressman McCaul’s office. Download the presentation (PPTX).
